PumaBiotech (@pumabiotech) / Twitter
Why Puma Biotechnology Shares Dropped 17.7% This Week | The Motley Fool
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib
PumaBiotech (@pumabiotech) / Twitter
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
SEC charges former Puma biotech exec with $1.1 million in insider trading
Puma Biotech Plunges on Sharp Drop in Cancer-Drug Sales - TheStreet
Puma Biotech shares slide after glimpse of trial data on cancer drug | Financial Times
Puma Biotechnology
Puma Biotechnology
Puma Biotechnology
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotech plunges on drug side effects
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib
Exhibitor Puma Biotechnology 02-20 - Scripps CME Connection
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology Reports Results of Neratinib (PB272) in P-III NALA Trial for 3L HER2-Positive Metastatic Breast Cancer
Puma Biotechnology: Risky Investment (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Inc
Puma Biotechnology
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters.com
Puma Biotech Gets $100M Loan to Boost Breast Cancer Drug - Los Angeles Business Journal
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Puma Biotechnology
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
